Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-Cell acute lymphoblastic leukemia: A group for research in adult acute lymphoblastic leukemia study

Journal of Clinical Oncology

Volumn 31, Issue 34, 2013, Pages 4333-4342

  Trinquand, Amélie ^a,b   Tanguy Schmidt, Aline ^e   Abdelali, Raouf Ben ^a,b   Lambert, Jérôme ^c   Beldjord, Kheira ^d   Lengliné, Etienne ^a,b,d   De Gunzburg, Noémie ^a,b   Payet Bornet, Dominique ^f   Lhermitte, Ludovic ^a,b   Mossafa, Hossein ^g   Lhéritier, Véronique ^h   Bond, Jonathan ^a,b   Huguet, Françoise ⁱ   Buzyn, Agnes ^a   Leguay, Thibaud ^j   Cahn, Jean Yves ^k   Thomas, Xavier ^h   Chalandon, Yves ⁿ   Delannoy, André ^o   Bonmati, Caroline ^l   Maury, Sebastien ^m   Nadel, Bertrand ^f   Macintyre, Elizabeth ^a,b   Ifrah, Norbert ^e   Dombret, Hervé ^d   Asnafi, Vahid ^a,b   more..

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d UNIVERSITÉ PARIS DIDEROT   (France)

^e Laboratoire d'Acoustique Environnementale)   (France)

^f CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^g LABORATOIRE CERBA   (France)

^h CENTRE HOSPITALIER LYON SUD   (France)

ⁱ CHU PURPAN   (France)

^j Haut Leveque's Hospital   (France)

^k UNIV GRENOBLE ALPES   (France)

^l UNIVERSITY HOSPITAL OF NANCY   (France)

^m HENRI MONDOR HOSPITAL   (France)

ⁿ GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^o Hospital de Jolimont   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FBXW7 PROTEIN; K RAS PROTEIN; NOTCH1 RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RAS PROTEIN; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; F BOX PROTEIN; FBXW7 PROTEIN, HUMAN; GUANOSINE TRIPHOSPHATASE; KRAS PROTEIN, HUMAN; MEMBRANE PROTEIN; NOTCH1 PROTEIN, HUMAN; NRAS PROTEIN, HUMAN; ONCOPROTEIN; PTEN PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; HAZARD RATIO; LOW RISK PATIENT; MUTATION; PRIORITY JOURNAL; ADULT; CLASSIFICATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE DELETION; GENETIC PREDISPOSITION; GENETICS; HUMAN; KAPLAN MEIER METHOD; MALE; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PHENOTYPE; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TIME; YOUNG ADULT; CLINICAL TRIAL; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

ADULT; CELL CYCLE PROTEINS; DISEASE-FREE SURVIVAL; DNA MUTATIONAL ANALYSIS; F-BOX PROTEINS; FEMALE; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; GTP PHOSPHOHYDROLASES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MEMBRANE PROTEINS; MULTIVARIATE ANALYSIS; MUTATION; PHENOTYPE; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS; PTEN PHOSPHOHYDROLASE; RAS PROTEINS; RECEPTOR, NOTCH1; RISK FACTORS; TIME FACTORS; UBIQUITIN-PROTEIN LIGASES; YOUNG ADULT;

EID: 84892935227     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.48.5292     Document Type: Article

References (33)

1. Pui CH, Evans WE: Treatment of acute lymphoblastic leukemia. N Engl J Med 354:166-178, 2006 (Pubitemid 43076714)
2. Aifantis I, Raetz E, Buonamici S: Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol 8:380-390, 2008 (Pubitemid 351595220)
3. Ben Abdelali R, Asnafi V, Leguay T, et al: Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/ FBXW7 mutations, but not of low ERG/BAALC expression: A GRAALL study. Blood 118:5099- 5107, 2011
4. De Keersmaecker K, Atak ZK, Li N, et al: Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia. Nat Genet 45:186-190, 2013
5. Ferrando AA, Neuberg DS, Staunton J, et al: Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1:75-87, 2002 (Pubitemid 41039178)
6. Soulier J, Clappier E, Cayuela JM, et al: HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood 106:274-286, 2005 (Pubitemid 40967203)
7. Van Vlierberghe P, Ferrando A: The molecular basis of T cell acute lymphoblastic leukemia. J Clin Invest 122:3398-3406, 2012
8. Zhang J, Ding L, Holmfeldt L, et al: The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481:157-163, 2012
9. Weng AP, Ferrando AA, Lee W, et al: Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306:269-271, 2004 (Pubitemid 39336870)
10. O'Neil J, Grim J, Strack P, et al: FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med 204:1813-1824, 2007 (Pubitemid 47236319)
11. Rowe JM, Buck G, Burnett AK, et al: Induction therapy for adults with acute lymphoblastic leukemia: Results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood 106:3760-3767, 2005 (Pubitemid 41739010)
12. Campana D: Minimal residual disease in acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2010:7-12, 2010
13. Huguet F, Leguay T, Raffoux E, et al: Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: The GRAALL-2003 study. J Clin Oncol 27:911- 918, 2009
14. Bonnet M, Loosveld M, Montpellier B, et al: Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia. Blood 117:6650-6659, 2011
15. Gutierrez A, Sanda T, Grebliunaite R, et al: High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia. Blood 114:647-650, 2009
16. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
17. Cox D: Regression models and life tables. J R Stat Soc B 34:187-220, 1972
18. Gönen M, Heller G: Concordance probability and discriminative power of proportional hazards regression. Biometrika 92:965-970, 2005 (Pubitemid 41681247)
19. Asnafi V, Buzyn A, Le Noir S, et al: NOTCH1/ FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): A Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study. Blood 113:3918-3924, 2009
20. Van Vlierberghe P, Pieters R, Beverloo HB, et al: Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia. Br J Haematol 143: 153-168, 2008
21. Germain RN, Stefanová I: The dynamics of T cell receptor signaling: Complex orchestration and the key roles of tempo and cooperation. Annu Rev Immunol 17:467-522, 1999 (Pubitemid 29241132)
22. Leslie NR, Downes CP: PTEN: The down side of PI 3-kinase signalling. Cell Signal 14:285-295, 2002 (Pubitemid 34164684)
23. Song MS, Salmena L, Pandolfi PP: The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 13:283-296, 2012
24. Guo W, Lasky JL, Chang CJ, et al: Multigenetic events collaboratively contribute to Pten-null leukaemia stem-cell formation. Nature 453:529-533, 2008 (Pubitemid 351733319)
25. Bandapalli OR, Zimmermann M, Kox C, et al: NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia. Haematologica 98:928-936, 2013
26. Zuurbier L, Petricoin EF 3rd, Vuerhard MJ, et al: The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia. Haematologica 97:1405-1413, 2012
27. Parikh C, Subrahmanyam R, Ren R: Oncogenic NRAS rapidly and efficiently induces CMML- and AML-like diseases in mice. Blood 108:2349-2357, 2006 (Pubitemid 44497519)
28. Zhang J, Wang J, Liu Y, et al: Oncogenic Kras-induced leukemogenesis: Hematopoietic stem cells as the initial target and lineage-specific progenitors as the potential targets for final leukemic transformation. Blood 113:1304-1314, 2009
29. Perentesis JP, Bhatia S, Boyle E, et al: RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia. Leukemia 18:685-692, 2004 (Pubitemid 38500186)
30. Van Vlierberghe P, Ambesi-Impiombato A, Perez-Garcia A, et al: ETV6 mutations in early immature human T cell leukemias. J Exp Med 208:2571- 2579, 2011
31. Asnafi V, Beldjord K, Libura M, et al: Agerelated phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy. Blood 104:4173-4180, 2004 (Pubitemid 39620171)
32. Digel W, Schultze J, Kunzmann R, et al: Poor prognosis of prethymic phenotype acute lymphoblastic leukemia (pre-T-ALL). Leukemia 8:1406- 1408, 1994 (Pubitemid 24262501)
33. Thiel E, Kranz BR, Raghavachar A, et al: Prethymic phenotype and genotype of pre-T (CD7-/ ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia. Blood 73:1247- 1258, 1989 (Pubitemid 19107430)